Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

31.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
31.3K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.4K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.4K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

6.5K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
6.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Italy's Landmark Obesity Law: The Long Road from Science to Policy.

Obesity facts·2026
Same author

Self-Templated Highly Porous Gold Electrodes for Antibiofouling Electrochemical (Bio)Sensors.

Nanomaterials (Basel, Switzerland)·2026
Same author

Capturing metabolic syndrome: new thresholds for insulin resistance and novel body composition indices.

International journal of obesity (2005)·2026
Same author

Author's response to comment re. "Nutri-Score effectiveness at improving consumer nutrition literacy, food choices, health, and healthy eating pattern adherence: A systematic review".

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Changes of in-vivo markers of platelet activation during the menstrual cycle in healthy pre-menopausal female individuals.

Communications medicine·2025
Same author

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial.

BMC medicine·2025
Same journal

Tirzepatide as a multi-organ integrator in metabolic diseases: a review of molecular mechanisms and clinical translation.

Endocrine·2026
Same journal

Effects of a single-dose denosumab on glucose and lipid homeostasis in young infertile men.

Endocrine·2026
Same journal

Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma with calcifications: short-term imaging outcomes.

Endocrine·2026
Same journal

Diabetic gastroparesis: pathophysiology and impact on insulin timing choices.

Endocrine·2026
Same journal

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Endocrine·2026
Same journal

Interpreting the TIR 3B nomogram as a rule-in rather than rule-out tool.

Endocrine·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K

Endocrine evaluation of erectile dysfunction.

Andrea Sansone1, Francesco Romanelli, Daniele Gianfrilli

  • 1Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, "Sapienza" University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy, andrea.sansone@uniroma1.it.

Endocrine
|April 8, 2014
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED) is common, but phosphodiesterase type 5 inhibitors only treat symptoms. A comprehensive endocrine evaluation is crucial for diagnosing underlying hormonal causes of ED beyond testosterone deficiency.

More Related Videos

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.6K

Related Experiment Videos

Last Updated: May 1, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.6K

Area of Science:

  • Endocrinology
  • Men's Health
  • Sexual Medicine

Background:

  • Erectile dysfunction (ED) affects up to 50% of men aged 50-70, linked to lifestyle and comorbidities.
  • Phosphodiesterase type 5 inhibitors (PDE5i) are first-line treatments but offer symptomatic relief, not cures.
  • The focus on PDE5i has reduced the emphasis on diagnosing the root causes of ED, particularly endocrinopathies.

Purpose of the Study:

  • To broaden the diagnostic endocrine work-up for erectile dysfunction.
  • To highlight the complexity of overt and subclinical endocrine conditions contributing to ED.
  • To guide clinicians in investigating hormonal imbalances beyond testosterone deficiency.

Main Methods:

  • Review of epidemiological data on sexual health and hormone levels.
  • Analysis of existing guidelines for ED diagnosis and treatment.
  • Exploration of the role of various hormones (LH, prolactin, TSH, FT4) in sexual function.

Main Results:

  • Testosterone deficiency is a marker for sexual and physical frailty.
  • Hormones such as LH, prolactin, TSH, and FT4 also play significant roles in sexual functioning.
  • Current guidelines predominantly focus on late-onset hypogonadism, neglecting other endocrine factors.

Conclusions:

  • A thorough endocrine evaluation is essential for comprehensive ED diagnosis.
  • Investigating a wider range of hormones is necessary to identify diverse endocrine causes of ED.
  • Understanding these complexities can lead to more effective etiological treatments for ED.